Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients

Published:2016-06-13 Issue:12 Volume:15 Page:1567-1574
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Cheng Daryl R¹²³,Barton Rebecca⁴,Greenway Anthea⁴⁵,Crawford Nigel W¹²³

Affiliation:

1. General Medicine, The Royal Children’s Hospital, Melbourne, VIC, Australia

2. Department of Paediatrics, The University of Melbourne, Melbourne, VIC, Australia

3. SAEFVIC, Murdoch Children’s Research Institute, Melbourne, VIC, Australia

4. Haematology Department, The Royal Children’s Hospital, Melbourne, VIC, Australia

5. Haematology Research Group, Murdoch Children’s Research Institute, Melbourne, VIC, Australia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2016.1193438

Reference88 articles.

1. Optimizing immunization in pediatric special risk groups

2. Vaccination in patients with immunosuppression

3. Vaccination in Paediatric Rheumatology

4. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre

5. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab use in paediatric nephrology practice in Türkiye: TRTX;Nephrology;2023-12-19

2. Vaccination in Individuals with Multiple Sclerosis – Part II;Turkish Journal Of Neurology;2023-07-03

3. International Delphi Consensus on the Management of AQP4-IgG+ NMOSD;Neurology Neuroimmunology & Neuroinflammation;2023-07

4. Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial;The Lancet Haematology;2023-06

5. Use of rituximab in pediatric nephrology practice;KIDNEYS;2023-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3